Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
National Pension Service grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 185,174 shares of the biopharmaceutical company’s stock after purchasing an additional 3,386 shares during the period. National Pension Service owned […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price objective boosted by Royal Bank of Canada from $820.00 to $830.00 in a research note issued to investors on Monday, MarketBeat.com reports. Royal Bank of Canada currently has a sector perform rating on the biopharmaceutical company’s stock. Several other research analysts also recently weighed in on […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price raised by Oppenheimer from $950.00 to $1,050.00 in a research report report published on Monday morning, MarketBeat reports. Oppenheimer currently has a market perform rating on the biopharmaceutical company’s stock. REGN has been the subject of several other reports. Guggenheim decreased their price target on […]
Cigna Investments Inc. New trimmed its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.0% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,272 shares of the biopharmaceutical company’s stock after selling 26 shares during the quarter. Cigna Investments […]
Canaccord Genuity Group upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a hold rating to a buy rating in a research report sent to investors on Monday, Marketbeat.com reports. They currently have $992.00 price target on the biopharmaceutical company’s stock, up from their previous price target of $720.00. A number of other brokerages […]